SCYNEXIS, Inc. Amortization of Intangible Assets
SCYNEXIS, Inc. (SCYX) reported Amortization of Intangible Assets of $400.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2024-03-28
- SCYNEXIS, Inc. amortization of intangible assets for fiscal 2023 was $400.00K, a 42.86% decline from fiscal 2022.
- SCYNEXIS, Inc. amortization of intangible assets for fiscal 2022 was $700.00K, a 250.00% increase from fiscal 2021.
- SCYNEXIS, Inc. amortization of intangible assets for fiscal 2021 was $200.00K.
| Period end | Amortization of Intangible Assets 12 month |
|---|---|
| 2023-12-31 | $400.00K 10-K · filed 2024-03-28 |
| 2022-12-31 | $700.00K 10-K · filed 2024-03-28 |
| 2021-12-31 | $200.00K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |